North Carolina Vaccine Facility Certified for the Next Pandemic
Seqirus certified to produce 150 million influenza pandemic vaccines
Source: precisionvaccinations.com
Stay updated with breaking news from Jersey Based Seqirus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Seqirus certified to produce 150 million influenza pandemic vaccines
New Jersey-based Seqirus today announced a new vaccine research and development facility will open in Massachusetts supporting the company's focus on a self-amplifying messenger RNA (sa-mRNA) technology platform, the next generation of mRNA technology. The new Waltham facility is expected to be fully operational by mid-2022.